Bayer AG
(Deutsche Boerse AG : BAYZF)

( )
BAYZF After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
AMRNAmarin Corp. Plc 4.82%5.221.6%$102.43m
JAZZJazz Pharmaceuticals Plc 4.02%99.532.3%$84.95m
VRXValeant Pharmaceuticals International, Inc. -1.31%13.5714.1%$79.85m
PRGOPerrigo Co. Plc -5.12%42.806.8%$76.72m
CTLTCatalent, Inc. 4.17%50.022.2%$70.10m
UTHRUnited Therapeutics Corp. -0.39%93.5314.3%$69.41m
HZNPHorizon Therapeutics Plc 5.48%31.856.5%$65.89m
AXSMAxsome Therapeutics, Inc. -0.23%55.661.9%$64.81m
ICLRICON plc -1.82%129.794.2%$63.65m
GWPHGW Pharmaceuticals Plc -0.57%84.526.2%$54.22m
ICPTIntercept Pharmaceuticals, Inc. 3.05%60.1816.8%$40.18m
SAGESAGE Therapeutics, Inc. 0.00%26.758.6%$34.98m
PBHPrestige Consumer Healthcare, Inc. 2.42%38.044.0%$33.28m
PCRXPacira Biosciences, Inc. 1.12%32.5810.4%$30.47m
ZGNXZogenix, Inc. 0.39%23.199.2%$29.61m

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.